BioLife Solutions (BLFS) Reports Prelim. 2Q Revenues Above Consensus; Boosts FY18 Revenue Guidance

Go back to BioLife Solutions (BLFS) Reports Prelim. 2Q Revenues Above Consensus; Boosts FY18 Revenue Guidance

BioLife Solutions Reports Second Quarter 2018 Preliminary Revenue of $5.2 Million, up 103% Year-over-Year and 36% Sequentially

July 2, 2018 8:00 AM EDT

BOTHELL, Wash., July 2, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today reported preliminary revenue for the three months ended June 30, 2018 and increased its revenue guidance for 2018.

... More